FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care

IDx-DR becomes the first autonomous, AI-based diagnostic system authorized for marketing by the FDA CORALVILLE, Iowa, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- IDx, a privately-held AI diagnostics company, announced today that the U.S... Devices, Ophthalmology, FDA, Product Launch IDx, IDx-DR, Diabetic Retinopathy

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2043737

Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news